This report contains market size and forecasts of PD-1 and PD-L1 Monoclonal Antibody in global, including the following market information:
Global PD-1 and PD-L1 Monoclonal Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PD-1 and PD-L1 Monoclonal Antibody Market Sales, 2017-2022, 2023-2028, (Units)
Global top five PD-1 and PD-L1 Monoclonal Antibody companies in 2021 (%)
The global PD-1 and PD-L1 Monoclonal Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-1 and PD-L1 Monoclonal Antibody include Merk, Bristol-Myers Squibb Company, Roche, Pfizer, AstraZeneca, Junshi Biosciences, Innovent, Hengrui and BeiGene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-1 and PD-L1 Monoclonal Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-1 and PD-L1 Monoclonal Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, by Type, 2021 (%)
PD-1
PD-L1
Global PD-1 and PD-L1 Monoclonal Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, by Application, 2021 (%)
Lung Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Nasopharyngeal Carcinoma
Head and Neck Cancer
Other
Global PD-1 and PD-L1 Monoclonal Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PD-1 and PD-L1 Monoclonal Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PD-1 and PD-L1 Monoclonal Antibody revenues share in global market, 2021 (%)
Key companies PD-1 and PD-L1 Monoclonal Antibody sales in global market, 2017-2022 (Estimated), (Units)
Key companies PD-1 and PD-L1 Monoclonal Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso